These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1103 related articles for article (PubMed ID: 34099652)

  • 1. SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care.
    Gutmann C; Takov K; Burnap SA; Singh B; Ali H; Theofilatos K; Reed E; Hasman M; Nabeebaccus A; Fish M; McPhail MJ; O'Gallagher K; Schmidt LE; Cassel C; Rienks M; Yin X; Auzinger G; Napoli S; Mujib SF; Trovato F; Sanderson B; Merrick B; Niazi U; Saqi M; Dimitrakopoulou K; Fernández-Leiro R; Braun S; Kronstein-Wiedemann R; Doores KJ; Edgeworth JD; Shah AM; Bornstein SR; Tonn T; Hayday AC; Giacca M; Shankar-Hari M; Mayr M
    Nat Commun; 2021 Jun; 12(1):3406. PubMed ID: 34099652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution and serologic response in SARS-CoV-2 induced ARDS: A cohort study.
    Schlesinger T; Weißbrich B; Wedekink F; Notz Q; Herrmann J; Krone M; Sitter M; Schmid B; Kredel M; Stumpner J; Dölken L; Wischhusen J; Kranke P; Meybohm P; Lotz C
    PLoS One; 2020; 15(11):e0242917. PubMed ID: 33232382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules.
    Stravalaci M; Pagani I; Paraboschi EM; Pedotti M; Doni A; Scavello F; Mapelli SN; Sironi M; Perucchini C; Varani L; Matkovic M; Cavalli A; Cesana D; Gallina P; Pedemonte N; Capurro V; Clementi N; Mancini N; Invernizzi P; Bayarri-Olmos R; Garred P; Rappuoli R; Duga S; Bottazzi B; Uguccioni M; Asselta R; Vicenzi E; Mantovani A; Garlanda C
    Nat Immunol; 2022 Feb; 23(2):275-286. PubMed ID: 35102342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19.
    Bermejo-Martin JF; González-Rivera M; Almansa R; Micheloud D; Tedim AP; Domínguez-Gil M; Resino S; Martín-Fernández M; Ryan Murua P; Pérez-García F; Tamayo L; Lopez-Izquierdo R; Bustamante E; Aldecoa C; Gómez JM; Rico-Feijoo J; Orduña A; Méndez R; Fernández Natal I; Megías G; González-Estecha M; Carriedo D; Doncel C; Jorge N; Ortega A; de la Fuente A; Del Campo F; Fernández-Ratero JA; Trapiello W; González-Jiménez P; Ruiz G; Kelvin AA; Ostadgavahi AT; Oneizat R; Ruiz LM; Miguéns I; Gargallo E; Muñoz I; Pelegrin S; Martín S; García Olivares P; Cedeño JA; Ruiz Albi T; Puertas C; Berezo JÁ; Renedo G; Herrán R; Bustamante-Munguira J; Enríquez P; Cicuendez R; Blanco J; Abadia J; Gómez Barquero J; Mamolar N; Blanca-López N; Valdivia LJ; Fernández Caso B; Mantecón MÁ; Motos A; Fernandez-Barat L; Ferrer R; Barbé F; Torres A; Menéndez R; Eiros JM; Kelvin DJ
    Crit Care; 2020 Dec; 24(1):691. PubMed ID: 33317616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of SARS-CoV-2 RNAemia and outcome in patients with coronavirus disease 2019.
    Tang K; Wu L; Luo Y; Gong B
    J Med Virol; 2021 May; 93(5):3165-3175. PubMed ID: 33590923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Acute Respiratory Syndrome Coronavirus 2 Viremia Is Associated With Coronavirus Disease 2019 Severity and Predicts Clinical Outcomes.
    Jacobs JL; Bain W; Naqvi A; Staines B; Castanha PMS; Yang H; Boltz VF; Barratt-Boyes S; Marques ETA; Mitchell SL; Methé B; Olonisakin TF; Haidar G; Burke TW; Petzold E; Denny T; Woods CW; McVerry BJ; Lee JS; Watkins SC; St Croix CM; Morris A; Kearney MF; Ladinsky MS; Bjorkman PJ; Kitsios GD; Mellors JW
    Clin Infect Dis; 2022 May; 74(9):1525-1533. PubMed ID: 34374761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19.
    Kawasuji H; Morinaga Y; Tani H; Yoshida Y; Takegoshi Y; Kaneda M; Murai Y; Kimoto K; Ueno A; Miyajima Y; Fukui Y; Kimura M; Yamada H; Sakamaki I; Yamamoto Y
    J Med Virol; 2022 Jan; 94(1):147-153. PubMed ID: 34411312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
    Weisblum Y; Schmidt F; Zhang F; DaSilva J; Poston D; Lorenzi JC; Muecksch F; Rutkowska M; Hoffmann HH; Michailidis E; Gaebler C; Agudelo M; Cho A; Wang Z; Gazumyan A; Cipolla M; Luchsinger L; Hillyer CD; Caskey M; Robbiani DF; Rice CM; Nussenzweig MC; Hatziioannou T; Bieniasz PD
    Elife; 2020 Oct; 9():. PubMed ID: 33112236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients.
    Sun B; Feng Y; Mo X; Zheng P; Wang Q; Li P; Peng P; Liu X; Chen Z; Huang H; Zhang F; Luo W; Niu X; Hu P; Wang L; Peng H; Huang Z; Feng L; Li F; Zhang F; Li F; Zhong N; Chen L
    Emerg Microbes Infect; 2020 Dec; 9(1):940-948. PubMed ID: 32357808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Frequency of SARS-CoV-2 RNAemia and Association With Severe Disease.
    Hogan CA; Stevens BA; Sahoo MK; Huang C; Garamani N; Gombar S; Yamamoto F; Murugesan K; Kurzer J; Zehnder J; Pinsky BA
    Clin Infect Dis; 2021 May; 72(9):e291-e295. PubMed ID: 32965474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.
    Chen X; Zhao B; Qu Y; Chen Y; Xiong J; Feng Y; Men D; Huang Q; Liu Y; Yang B; Ding J; Li F
    Clin Infect Dis; 2020 Nov; 71(8):1937-1942. PubMed ID: 32301997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between detectable SARS-COV-2 RNA in anal swabs and disease severity in patients with coronavirus disease 2019.
    Lin W; Xie Z; Li Y; Li L; Wen C; Cao Y; Chen X; Ou X; Hu F; Li F; Tang X; Cai W; Li L
    J Med Virol; 2021 Feb; 93(2):794-802. PubMed ID: 32672840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Kinetics of SARS-CoV-2 Antibody Development Is Associated with Clearance of RNAemia.
    Wang C; Li Y; Kaplonek P; Gentili M; Fischinger S; Bowman KA; Sade-Feldman M; Kays KR; Regan J; Flynn JP; Goldberg MB; Hacohen N; Filbin MR; Lauffenburger DA; Alter G; Li JZ
    mBio; 2022 Aug; 13(4):e0157722. PubMed ID: 35762593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 RNAemia and Disease Severity in COVID-19 Patients.
    Lawrence Panchali MJ; Kim CM; Seo JW; Kim DY; Yun NR; Kim DM
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological Characterization of Critically Ill Patients With COVID-19 in the United Kingdom: Interactions of Viral Load, Antibody Status, and B.1.1.7 Infection.
    Ratcliff J; Nguyen D; Fish M; Rynne J; Jennings A; Williams S; Al-Beidh F; Bonsall D; Evans A; Golubchik T; Gordon AC; Lamikanra A; Tsang P; Ciccone NA; Leuscher U; Slack W; Laing E; Mouncey PR; Ziyenge S; Oliveira M; Ploeg R; Rowan KM; Shankar-Hari M; Roberts DJ; Menon DK; Estcourt L; Simmonds P; Harvala H;
    J Infect Dis; 2021 Aug; 224(4):595-605. PubMed ID: 34031695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection.
    Lapp SA; Edara VV; Lu A; Lai L; Hussaini L; Chahroudi A; Anderson LJ; Suthar MS; Anderson EJ; Rostad CA
    PLoS One; 2021; 16(8):e0256482. PubMed ID: 34449792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible inhibition of GM-CSF production by SARS-CoV-2 spike-based vaccines.
    Li J; Wang P; Tracey KJ; Wang H
    Mol Med; 2021 May; 27(1):49. PubMed ID: 34022793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients.
    Tang J; Ravichandran S; Lee Y; Grubbs G; Coyle EM; Klenow L; Genser H; Golding H; Khurana S
    Nat Commun; 2021 Feb; 12(1):1221. PubMed ID: 33619281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle.
    Mondal T; Shivange G; Habieb A; Tushir-Singh J
    Microbiol Spectr; 2022 Feb; 10(1):e0236421. PubMed ID: 35138160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On-admission SARS-CoV-2 RNAemia as a single potent predictive marker of critical condition development and mortality in COVID-19.
    Miki S; Sasaki H; Horiuchi H; Miyata N; Yoshimura Y; Miyazaki K; Matsumura T; Takahashi Y; Suzuki T; Matano T; Kawana-Tachikawa A; Tachikawa N
    PLoS One; 2021; 16(7):e0254640. PubMed ID: 34255796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.